Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corneal sensation after 1, 2, or 3 drops of tetracaine
ACTRN12621001289808Phase 4Completed
- Sponsor
- Universidad Autónoma de Yucatán
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tetracaine in corneal hypesthesia (3 arms), sponsored by Universidad Autónoma de Yucatán. Primary endpoint: Corneal sensation. Started Dec 2019; status: completed.
02
Drugs
tetracaine
03
Conditions
corneal hypesthesia
Beyond the preview
Go deeper on ACTRN12621001289808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001289808.